Fraser Cunningham

Fraser Cunningham is an experienced medicinal chemist currently serving as Associate Director of Medicinal Chemistry at Recursion since November 2024. Previously, Fraser held positions at Exscientia as Associate Director of Drug Design and Senior Portfolio Manager, and at the University of Dundee, leading various teams in medicinal chemistry and coronavirus-related projects. Fraser's earlier experience includes significant roles at GSK, contributing as a Lead Chemist and Senior Scientist in drug development across multiple therapeutic areas, and a PhD focused on malaria research from the University of Leeds. Fraser also completed undergraduate studies in Chemistry with Pharmaceutical Chemistry at Heriot-Watt University.